ContractMaster Clinical Trial Agreement • January 23rd, 2017
Contract Type FiledJanuary 23rd, 2017AMENDMENT NO. 1to the Master Clinical Trial Agreement dated as of 28 June 2016 (“Agreement”) DODATEK č. 1K Rámcové Smlouvě o klinickém hodnocení uzavřenou dne 28.06.2016 (“Smlouva”) by and between Boehringer Ingelheim RCV GmbH & Co KGDr. Boehringer-Gasse 5-11,1121 Vienna, AustriaVAT-ID-No.: ATU 64226215(hereinafter referred to as "Sponsor") Uzavřena mezi Boehringer Ingelheim RCV GmbH & Co KGDr. Boehringer-Gasse 5-11,1121 Vienna, AustriaDIČ: ATU 64226215(dale jen „Zadavatel”) and Fakultní nemocnice Olomouc,I.P. Pavlova 6, 779 00 Olomouc Responsible unit: doc. MUDr. Roman Havlík, Ph.D., ředitel VAT-ID-No. resp. Taxpayer Ident. No.: 00098892/ CZ00098892(hereinafter referred to as "Institution") a Fakultní nemocnice Olomouc,I.P. Pavlova 6, 779 00 Olomouc, Czech RepublicOdpovědný útvar: doc. MUDr. Roman Havlík, Ph.D., ředitel DIČ/IČ:00098892/ CZ00098892(dále jen „Zdravotnické zařízení“) WHEREAS, Sponsor and Institution have entered into the Agreement. WHEREAS, Sponsor and Institution desire